Approved COVID-19 Vaccines
As of late August 2025, the U.S. Food and Drug Administration (FDA) has approved updated versions of the COVID-19 vaccines from Pfizer, Moderna and Novavax. These updated shots are intended to better protect against currently circulating variants.
The 2024–2025 formulations of the following vaccines are approved for certain groups: